Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

REALMUTO, Sabrina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.357
EU - Europa 4.663
AS - Asia 3.298
SA - Sud America 464
AF - Africa 119
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 12
Totale 14.935
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.244
IT - Italia 1.408
RU - Federazione Russa 1.117
SG - Singapore 1.069
CN - Cina 853
FI - Finlandia 565
BR - Brasile 370
VN - Vietnam 352
HK - Hong Kong 291
DE - Germania 248
IE - Irlanda 230
PL - Polonia 220
FR - Francia 171
GB - Regno Unito 171
UA - Ucraina 152
KR - Corea 144
JP - Giappone 119
IN - India 90
BD - Bangladesh 86
BE - Belgio 82
NL - Olanda 82
IR - Iran 56
CA - Canada 46
SE - Svezia 45
IQ - Iraq 40
RO - Romania 39
TR - Turchia 39
MX - Messico 35
AR - Argentina 34
EG - Egitto 33
ES - Italia 32
AT - Austria 24
CI - Costa d'Avorio 24
ID - Indonesia 22
AU - Australia 20
UZ - Uzbekistan 18
PK - Pakistan 17
CZ - Repubblica Ceca 15
MA - Marocco 15
VE - Venezuela 15
GR - Grecia 13
KE - Kenya 13
EC - Ecuador 12
NP - Nepal 12
MY - Malesia 11
EU - Europa 10
HN - Honduras 10
LT - Lituania 10
ZA - Sudafrica 10
CL - Cile 9
IL - Israele 9
JO - Giordania 9
SA - Arabia Saudita 9
CO - Colombia 8
TW - Taiwan 8
DZ - Algeria 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
JM - Giamaica 6
PH - Filippine 6
PY - Paraguay 6
TH - Thailandia 6
DK - Danimarca 5
KZ - Kazakistan 5
MD - Moldavia 5
AL - Albania 4
GE - Georgia 4
LB - Libano 4
UY - Uruguay 4
AZ - Azerbaigian 3
CR - Costa Rica 3
ET - Etiopia 3
HU - Ungheria 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
KG - Kirghizistan 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BS - Bahamas 1
CY - Cipro 1
DM - Dominica 1
GA - Gabon 1
GF - Guiana Francese 1
GT - Guatemala 1
GY - Guiana 1
Totale 14.923
Salva come PNG Salva come JPEG
Città #
Ashburn 890
Singapore 680
Fairfield 517
Chandler 436
San Jose 326
Woodbridge 307
Ann Arbor 292
Hong Kong 279
Wilmington 256
Houston 241
Seattle 233
Moscow 229
Dublin 228
Cambridge 176
Zgierz 172
Palermo 158
Medford 142
Beijing 125
Ho Chi Minh City 121
Des Moines 111
Nanjing 108
Los Angeles 107
Tokyo 106
Milan 103
New York 103
Dallas 98
Princeton 88
Boardman 87
Jacksonville 80
Santa Clara 76
Hanoi 75
Council Bluffs 72
Lauterbourg 72
Brussels 71
The Dalles 66
Frankfurt am Main 56
Seoul 55
Rome 53
Altamura 52
Shenyang 43
Tulsa 41
Lawrence 40
Changsha 39
Dearborn 39
Buffalo 38
Helsinki 37
San Diego 37
Jinan 32
Orem 32
Venice 32
Nanchang 29
Hebei 28
São Paulo 28
Jiaxing 25
Abidjan 24
Florence 24
Tianjin 24
London 23
Nuremberg 23
Phoenix 23
Verona 23
Tehran 22
Zhengzhou 22
Amsterdam 21
Da Nang 19
Warsaw 19
Naples 18
Baghdad 17
Chicago 17
Saint Petersburg 17
Chennai 16
Guangzhou 16
Hangzhou 16
Seongnam 16
Toronto 16
Giza 15
Munich 15
Washington 15
Atlanta 14
Belo Horizonte 14
Brno 14
Brooklyn 14
Haiphong 14
Ningbo 14
Falls Church 13
Hefei 13
Kumar 13
Ludwigshafen am Rhein 13
Montreal 13
New Delhi 13
Turin 13
Haikou 12
Istanbul 12
Norwalk 12
Redwood City 12
Tashkent 12
Ankara 11
Kraków 11
Poplar 11
Rio de Janeiro 11
Totale 8.707
Salva come PNG Salva come JPEG
Nome #
Emotion recognition from facial expressions: a normative study of the Ekman 60-Faces Test in the Italian population. 609
Four cases of progressive multifocal leukoencephalopathy in iatrogenic immunocompromised patients 364
Quantitative EEG differentiate Multiple Sclerosis with and without Cognitive Impairment from healthy controls at the beginning of the disease: preliminary data 351
Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: A cohort study 283
Anodal transcranial direct current stimulation over the right hemisphere improves auditory comprehension in a case of dementia 275
Cardiovascular comorbidity in multiple sclerosis patients treated with mitoxantrone therapy: a cohort study 268
Effect of extracellular vesicles from CSF of multiple sclerosis patients and healthy controls on astrocytes in culture 260
VDBP, CYP27B1, and 25-Hydroxyvitamin D Gene Polymorphism Analyses in a Group of Sicilian Multiple Sclerosis Patients 260
A population-based survey of cognitive performance in a Sicilian elderly community. 257
EARLY AND LATE MORTALITY OF SPONTANEOUS HEMORRHAGIC TRANSFORMATION OF ISCHEMIC STROKE 255
Klotho and vitamin D in multiple sclerosis: an Italian study 255
Sleep quality in caregivers of patients with Alzheimer’s disease and Parkinson’s disease and its relationship to quality of life 254
Application of tRNS to improve multiple sclerosis fatigue: a pilot, single-blind, sham-controlled study 249
Clinical features, disease course and prognosis in patients with paediatric and young adult onset multiple sclerosis 245
Differences in intercellular communication during clinical relapse and gadolinium-enhanced MRI in patients with relapsing remitting multiple sclerosis: A study of the composition of extracellular vesicles in cerebrospinal fluid 241
The Ekman 60-faces test: an italiana normative study 233
Insidious onset of Pisa syndrome after rasagiline therapy in a patient with Parkinson’s disease 232
Anodal tDCS of the swallowing motor cortex for treatment of dysphagia in multiple sclerosis: a pilot open-label study 231
Quantitative EEG differentiates multiple sclerosis with and without cognitive impairment from healthy controls at the beginning of the disease: preliminary data 223
DYSAUTONOMIC DYSFUNCTION IN PARKINSON’DISEASE BY SCOPA-AUT SCALE 213
Application of tRNS to improve Multiple Sclerosis Fatigue: a sham-controlled study 205
Neurofunctional correlates of attention rehabilitation in Parkinson's disease: an explorative study 200
Extracellular vesicles isolated by cerebrospinal fluid as biomarkers of inflammation in multiple sclerosis and inflammatory neurological diseases. 200
REM sleep behavior disorder in a patient with frontotemporal dementia 194
Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab: Evidence From an Italian Spontaneous, Prospective, and Observational Study (the TY-STOP Study). 194
Social cognition dysfunctions in patients with epilepsy: Evidence from patients with temporal lobe and idiopathic generalized epilepsies. 194
Lesion Load May Predict Long-Term Cognitive Dysfunction in Multiple Sclerosis Patients 190
Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers 187
Thalamic stroke mimicking frontotemporal dementia: a case report 186
Frontal dementia related to thalamic stroke: a case report. 178
Clinical features and disease out come in patients with pediatric and young adult onset Multiple Sclerosis 177
Frequency and clinical features of progranulin mutation carriers in a series of patients affected by frontotemporal lobar de generation: report of a novel mutation 175
IMMUNOSUPPRESSANT TREATMENT AND CANCER RISK IN A COHORT OF PATIENTS AFFECTED BY MULTIPLE SCLEROSIS 174
DYSAUTOMIC DISFUNCTON OCCURS EARLY IN PARKINSON DISEASE 174
PARKINSON’S DISEASE AND PARKINSON’S DISEASE FAMILIAL HISTORY. RESULTS OF A CASE-CONTROL STUDY 173
Tumor diagnosis preceding Alzheimer's disease onset: is there a link between cancer and Alzheimer's disease? 172
NEURODEGENERATION IN MULTIPLE SCLEROSIS: COMPARISON BETWEEN CLINICAL, NEUROPSYCHOLOGICAL, MRI,AND OPTICAL COHERENCE TOMOGRAPHY PARAMETERS 170
Frequency of cognitive impairment and factors associated in outpatients with Parkinson’s disease 168
Frequency of John Cunningham virus (JCV) DNA and of antibodies against JCV in patients affected by multiple sclerosis and their relationship with natalizumab therapy 167
ELECTROCARDIOGRAPHIC FINDINGS IN PATIENTS WITH DEMENTIA. 163
Rey-Osterrieth Complex figure performance in patients with degenerative dementia using Boston Qualitative Scoring System 158
Reversible Pisa Syndrome in a patient with Parkinson's Disease on rasagiline therapy 157
Clinical and instrumental predictors of efficacy of natalizumab therapy in the course of multiple sclerosis: a retrospective study from a single centre 156
Purine metabolism and Multiple Sclerosis: different pattern according to different disease stage and different clinical form. 152
Clinical and instrumental predictors of efficacy of Natalizumab therapy in multiple sclerosis patients: a retrospective study from a single centre 151
PRIMARY PROGRESSIVE CROSSED APHASIA IN A DEXTRAL WOMAN 150
Quetiapine dose-sparing effect with addiction of memantine: two cases report of Lewy Body disease and dementia associated with Parkinson’s disease 150
Chronic acquired hepatocerebral degeneration or Parkinson Disease? A case report 150
Clinical and Instrumental Findings and Disability Progression in Primary Progressive and Progressive Relapsing Multiple Sclerosis: A Comparison Study of a Sicilian Group of Patients 149
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study 149
Frequency of Mitoxantrone related heart involvement in patients affected by Multiple Sclerosis 147
Modulation of action tremor by repetitive transcranial magnetic stimulation in multiple sclerosis patients 147
Pisa syndrome after rasagiline therapy in a patient with Parkinson’s disease 146
PREGNANCIES MODIFY RELAPSES AND PROGRESSION IN MULTIPLE SCLEROSIS 145
Approccio multidimensionale ai disturbi non motori della Malattia di Parkinson 139
In patient’s with Parkinson disease, autonomic symptoms are frequent and associated with other non-motor symptoms 139
COGNITIVE IMPAIRMENT IN PATIENTS WITH PARKINSON’S DISEASE 138
RISK FACTORS FOR DYSKINESIAS IN PATIENTS WITH PARKINSON'S DISEASE 134
Sleep and sleepiness in Parkinson’s disease: result of a “spontaneous” observational study on rotigotine 134
Heart involvement in patients treated with mitoxantrone for multiple sclerosis 134
Back to the life: a case of tretable dementia 133
Emotion recognition in temporal lobe epilepsy and idiopathic generalized epilepsy 132
Sleep disturbances and dysautonomic dysfunction are associated in patients with Parkinson’s disease 130
EXTRACELLULAR VESICLES IN CEREBROSPINAL FLUID AS MARKERS OF CNS INFLAMMATION 128
Return of disease activity after natalizumab therapy discontinuation in patients with multiple sclerosis: frequency and clinical and instrumental predictors of reactivation 123
Sleep quality in caregivers of Parkinson’s disease and Alzheimer’s disease patients and its relationship to quality of life 123
Clinical Features and disease outcome in pt with pediatric and young adult onset multiple sclerosis 122
INFLUENCE OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (RTMS) ON ACTION TREMOR IN MULTIPLE SCLEROSIS PATIENTS 119
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 117
EMpathy ability and emotion recognition in temporal lobe epilepsy and idhiopathic generalizede epileps 115
Primary Progressive and progressive relapsing multiple sclerosis show different clinical and instrumental findings and disability progression? A comparison study on a Sicilian database 113
Toxic effects on astrocytes of extracellular vesicles from CSF of multiple sclerosis patients: A pilot in vitro study 108
Computer-assisted cognitive remediation for Parkinson’s disease 107
Urinary dysfunction in Parkinson’s disease patients 107
Natalizumab therapy of relapsing-remitting multiple sclerosis: an evaluation of the safety profile and a comparison of efficacy with interferon beta therapy 106
Identification of three novel progranulin mutations in a series of patients affected by sporadic and familial frontotemporal lobar de generation. Platform Presentation 102
Tumor diagnosis preceding Alzheimer’s disease: a case-control study 102
Natalizumab Discontinuation after the 24th Course: Which Is Way? The TY-STOP Study 98
Psychosis as adverse effect of cholinesterase inhibitors: two case reports of probable Alzheimer disease in treatment with galantamine 97
Primary progressive crossed aphasia in dextrals: report of three cases 97
Mitochondrial DNA TRNACYS mutation in a family with frontotemporal dementia and Parkinson’s disease 91
Multiple reversibile MR signals in course of Epstein-Barr virus encephalitis 90
Discontinuation of treatment with Natalizumab after 24 courses. Report from spontaneous, observational, prospective study (TYSTOP). 89
Lifestyle factors and multiple sclerosis: a case control study 83
Looking for the best therapeutical stretegy after the 24th natalizumab adiministretion. The TY-STOP study 79
Reduced striatal dopamine transporter binding in posterior cortical atrophy 79
Purine metabolism and multiple sclerosis: pattern varies according to disease stage and clinical form 77
Treatment of multiple sclerosis patients after 24 Natalizumab doses: a prospective observational study: the TY-STOP 70
TREATMENT CHOICE AFTER 24 NATALIZUMAB DOSES IN PATIENTS WITH MULTIPLE SCLEROSIS: A PROSPECTIVE OBSERVATIONAL STUDY, THE TY-STOP 62
LATE MORTALITY OF HEMORRHAGIC TRANSFORMATION OF ISCHEMIC STROKE 51
null 44
null 37
null 3
Totale 15.258
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.784
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.784
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021112 0 0 0 0 0 0 0 0 0 0 0 112
2021/2022963 49 205 40 47 31 43 31 64 105 110 45 193
2022/20231.577 149 184 51 151 272 253 95 125 177 18 84 18
2023/2024817 35 122 37 82 75 143 44 63 17 46 27 126
2024/20251.656 63 96 92 172 109 51 92 96 128 164 244 349
2025/20265.542 489 141 299 387 561 904 724 662 492 519 244 120
Totale 15.258